comprehensive -WSS

comprehensive

author：knowledge 2025-10-02 20:52:37 - browse：2

Principal Deputy FDA Commissioner Janet Woodcock Stefani Reynolds/The New York Times via AP

WASHINGTON — Principal Deputy FDA Commissioner Janet Woodcock will retire early next year from the Food and Drug Administration after helping steer the agency through an historic period of medical advances during nearly four decades in key leadership positions, she confirmed to STAT Thursday.

Woodcock, a doctor with a chemistry degree, joined FDA in 1986 at its biologics center, where she oversaw the approval of the first biotechnology-based treatments for multiple sclerosis and cystic fibrosis. In 1994, she was named director of the drug center, where she played a key role in guiding some of the most impactful changes to the regulation of medicine, according to Trump administration FDA Commissioner Scott Gottlieb.

Woodcock envisioned that antibody drugs would become a backbone of therapy and created a more predictable regulatory path for their review and approval, Gottlieb said. She presided over a major expansion and modernization of the generic drug program, standardizing reviews in a way that allowed the industry to become safer and more robust, and crafted the reform of over-the-counter drug reviews.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： My daughter's legacy lives on through her writing, phage therapy

WSS

What to do when lifesaving products contribute to climate change

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

How to pay for weight loss drugs and save Medicare

CDC director unscathed in first congressional testimony

Pharma companies must ensure equitable access to obesity drugs

30 years of 'Listening to Prozac'

Wikipedia

comprehensive

explore

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Takeda, Janssen join wearable maker to measure scratching

Virginia high school admissions case could be legal follow

Organ aging and disease risk measured by new blood test

New air purifier tech could be key to improving indoor air quality

STAT Virtual Event: ASCO Recap, Live!

Medicare proposal to cover medical devices draws a mixed reaction

Statins may not be needed by millions of people, study suggests

Hepatitis C has a cure — but many Americans still lack access to it

Cigna, Humana reportedly in talks to merge

focus

Curing rare childhood diseases will falter unless Congress steps up

FDA investigates CAR

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

Report captures long Covid’s disabling effects and policy challenges

Mayo Clinic plans $5B tech

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

hotspot

focus

focus

Wikipedia